We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cross-Over Evaluation of Two Lubricating Eye Drops

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00493662
First Posted: June 28, 2007
Last Update Posted: January 15, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Innovative Medical
  Purpose
To evaluate the efficacy of two lubricating eye drops for the treatment of dry eye signs and symptoms.

Condition Intervention Phase
Dry Eye Drug: Polyethylene Glycol 400 0.4% Drug: Propylene Glycol 0.3% Drug: 0.15% sodium Hyaluronate Drug: sodium chloride Drug: sodium phosphate monobasic Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single

Resource links provided by NLM:


Further study details as provided by Innovative Medical:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  1. Patients 18 yrs or older
  2. Males or females
  3. Any race or ethnic background
  4. Patients with present ocular surface discomfort and a SESoD score of at least 2

Exclusion Criteria:

  1. Corneal refractive surgery within 6 months of this study.
  2. Contact lens use on day of examination.
  3. Corneal ectasia.
  4. Current use of Restasis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00493662


Locations
United States, Pennsylvania
Hazleton Eye Specialists
Hazleton, Pennsylvania, United States, 18202
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Tom Kislan, OD Hazleton Eye Specialists
  More Information

ClinicalTrials.gov Identifier: NCT00493662     History of Changes
Other Study ID Numbers: 5310
First Submitted: June 26, 2007
First Posted: June 28, 2007
Last Update Posted: January 15, 2008
Last Verified: January 2008

Additional relevant MeSH terms:
Hyaluronic Acid
Adjuvants, Immunologic
Immunologic Factors
Physiological Effects of Drugs
Viscosupplements
Protective Agents